Ads
related to: warnings for phenylpropanolamine treatment for diabetes mellitus- See the FAQs
Get the Answers to Frequently
Asked Questions Today.
- View Patient Stories
Watch Videos of Patient Stories
Today to Start Your T1D Journey.
- View T1D Organizations
Stay Connected. Learn About
T1D Organizations Today.
- Join the Support Program
View Resources & Copay Assistance.
Terms & Conditions Apply.
- Talk to Your Doctor
Download the Discussion Guide
to Start the Conversation Today.
- Get Screened Today
Discover the Importance of Early
Screening. Learn More Now.
- See the FAQs
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]
Phenylpropanolamine was first synthesized in the early 20th century, in or around 1910. [21] [11] It was patented as a mydriatic in 1913. [21] The pressor effects of phenylpropanolamine were characterized in the late 1920s and the 1930s. [21] Phenylpropanolamine was first introduced for medical use by the 1930s. [23] [11]
Diabetes mellitus or hyperthyroidism, since signs and symptoms of hypoglycemia may be masked; Peripheral artery disease and Raynaud syndrome, which may be exacerbated; Phaeochromocytoma, as hypertension may be aggravated without prior alpha blocker therapy; Myasthenia gravis, which may be worsened; Other drugs with bradycardic effects
Semaglutide is not a WHO-recommended treatment for diabetes management due to its current high cost, but the agency said it was working on a rapid advice guideline on use of GLP-1 drugs for ...
Canagliflozin is indicated to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes; to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease; and to reduce the risk of end-stage kidney disease, worsening of kidney function, heart-related death, and being hospitalized for ...
Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.
Ad
related to: warnings for phenylpropanolamine treatment for diabetes mellitus